Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic Myeloproliferative Disorders
- 1 April 2007
- journal article
- research article
- Published by Elsevier BV in The Journal of Molecular Diagnostics
- Vol. 9 (2), 272-276
- https://doi.org/10.2353/jmoldx.2007.060133
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- JAK2 V617F in Myeloid Disorders: Molecular Diagnostic Techniques and Their Clinical Utility: A Paper from the 2005 William Beaumont Hospital Symposium on Molecular PathologyThe Journal of Molecular Diagnostics, 2006
- Diagnostic Assays for the JAK2 V617F Mutation in Chronic Myeloproliferative DisordersAmerican Journal of Clinical Pathology, 2006
- Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alphaBlood, 2006
- A quantitative assay for JAK2V617F mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresisLeukemia, 2006
- Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosisLeukemia, 2005
- Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disordersBlood, 2005
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisCancer Cell, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- A Unique Activating Mutation in JAK2 (V617F) Is at the Origin of Polycythemia Vera and Allows a New Classification of Myeloproliferative DiseasesHematology, 2005